Suvd Nadmid

Dr. Suvd Nadmid

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Metabolic Engineering
Verified
Journal Article
Closed access
MMMaksym Myronovskyi
Maksym Myronovskyi
BRBirgit Rosenkränzer
Birgit Rosenkränzer
SNSuvd Nadmid
Suvd Nadmid
Petar PujicPetar Pujic
Petar Pujic
PNPhilippe Normand
Philippe Normand
ALAndriy Luzhetskyy
Andriy Luzhetskyy

10 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CPConstanze Paulus
Constanze Paulus
YRYuriy Rebets
Yuriy Rebets
BTBogdan Tokovenko
Bogdan Tokovenko
SNSuvd Nadmid
Suvd Nadmid
LTLarisa P. Terekhova
Larisa P. Terekhova
ALAndriy Luzhetskyy
Andriy Luzhetskyy
Marine actinobacteria are drawing more and more attention as a promising source of new natural products. Here we report isolation, genome sequencing and metabolic profiling of new strain Streptomyces sp. MP131-18 isolated from marine sediment sample collected in the Trondheim Fjord, Norway. The 16S rRNA and multilocus phylogenetic analysis showed that MP131-18 belongs to the genus Streptomyces. The genome of MP131-18 isolate was sequenced, and 36 gene clusters involved in the biosynthesis of 18 different types of secondary metabolites were predicted using antiSMASH analysis. The combined genomics-metabolics profiling of the strain led to the identification of several new biologically active compounds. As a result, the family of bisindole pyrroles spiroindimicins was extended with two new members, spiroindimicins E and F. Furthermore, prediction of the biosynthetic pathway for unusual α-pyrone lagunapyrone isolated from MP131-18 resulted in foresight and identification of two new compounds of this family – lagunapyrones D and E. The diversity of identified and predicted compounds from Streptomyces sp. MP131-18 demonstrates that marine-derived actinomycetes are not only a promising source of new natural products, but also represent a valuable pool of genes for combinatorial biosynthesis of secondary metabolites.

1 September 2018 in Metabolic Engineering
Verified
Journal Article
Closed access
LHLiliya Horbal
Liliya Horbal
FMFilipe Marques
Filipe Marques
SNSuvd Nadmid
Suvd Nadmid
MMMarta V. Mendes
Marta V. Mendes
ALAndriy Luzhetskyy
Andriy Luzhetskyy

14 October 2013 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
THThomas Hoffmann
Thomas Hoffmann
SMStefan Müller
Stefan Müller
SNSuvd Nadmid
Suvd Nadmid
RGRonald Garcia
Ronald Garcia
RMRolf Müller
Rolf Müller

24 July 2014 in Organic Letters
Verified
Journal Article
Closed access
SNSuvd Nadmid
Suvd Nadmid
APAlberto Plaza
Alberto Plaza
GLGianluigi Lauro
Gianluigi Lauro
RGRonald Garcia
Ronald Garcia
GBGiuseppe Bifulco
Giuseppe Bifulco
RMRolf Müller
Rolf Müller

2 June 2016 in Future Medicinal Chemistry
Verified
Journal Article
Open access
CMChristine K Maurer
Christine K Maurer
MFMartina Fruth
Martina Fruth
MEMartin Empting
Martin Empting
OAOlga Avrutina
Olga Avrutina
JHJörn Hoßmann
Jörn Hoßmann
RHRolf W Hartmann
Rolf W Hartmann
Aim: CsrA is a global post-transcriptional regulator protein affecting mRNA translation and/or stability. Widespread among bacteria, it is essential for their full virulence and thus represents a promising anti-infective drug target. Therefore, we aimed at the discovery of CsrA–RNA interaction inhibitors. Results & methodology: We followed two strategies: a screening of small molecules (A) and an RNA ligand-based approach (B). Using surface plasmon resonance-based binding and fluorescence polarization-based competition assays, (A) yielded seven small-molecule inhibitors, among them MM14 (IC50 of 4 µM). (B) resulted in RNA-based inhibitor GGARNA (IC50 of 113 µM). Conclusion: The first small-molecule inhibitors of the CsrA–RNA interaction were discovered exhibiting micromolar affinities. These hits represent tools to investigate the effects of CsrA–RNA interaction inhibition on bacterial virulence.